Working together for safe medicines in the EU

News 06/05/2019

EMA launches a social media campaign to highlight how the European medicines regulatory network keeps medicines available in Europe safe and effective.

As of today, EMA will start sharing a series of info-cards on its Twitter and LinkedIn accounts.

The visuals describe the added value of European cooperation in keeping medicines safe, from the pooling of resources to better monitor and analyse safety information across the continent, to raising safety standards and allowing patients to directly report side effects and identify legally operating online pharmacies and retailers.

‘Keeping medicines safe’ is a priority for EMA, the European Commission and the network of national competent authorities which provides the Agency with the best-available scientific expertise in the EU for the regulation of medicines.

EMA encourages stakeholders to support the campaign by sharing the info-cards on social media.

Keeping medicines safe

 

Keeping medicines safe

 

Reporting side effects

 

Importance of package leaflet

 

Falsified medicines

How useful was this page?

Add your rating
Average
7 ratings
3 ratings
1 rating